Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The rapid rise of AI could potentially change healthcare forever, leading to faster diagnoses and allowing providers to spend more time communicating directly with patients. According to a new report from the Brookings Institution, however, there are also risks associated with AI in healthcare that must be addressed.
Google was hoping to release a massive dataset of chest x-rays to the public in 2017, but had to cancel at the last minute after receiving an urgent call from the National Institutes of Health (NIH).
Machine learning can help predict the life expectancy of heart failure patients, according to new research published in the European Journal of Heart Failure.
AI can identify patients at risk of dying—of any cause—within the next year or of developing an irregular heartbeat, according to two new studies to be presented at the American Heart Association’s Scientific Sessions 2019.
RSNA 2019, the world’s largest radiology conference, kicks off at Chicago’s McCormick Place on Sunday, Dec. 1. This year's show promises to include more AI content than ever before.
